AMD vs IBRX · P/E 157, rev $11.54B vs rev $113.3M
Advanced Micro Devices Inc (AMD) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
Latest reported IBRX revenue for 2025-12-31 was $113.3M. Net income was -$351.4M. Revenue was up 668.3% from 2024-12-31 to 2025-12-31. IBRX currently screens at market cap $7.88B.
AMD currently screens at market cap $760.48B and trailing P/E 156.5. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the AMD and IBRX stock pages for the full models.
Not investment advice.